Richard J. Daly - Jun 4, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Richard J. Daly
Stock symbol
CPRX
Transactions as of
Jun 4, 2024
Transactions value $
-$116,335
Form type
4
Date filed
6/5/2024, 05:00 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $160K +40K +18.85% $4.01* 252K Jun 4, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$277K -17.3K -6.87% $15.98 235K Jun 4, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -40K -2.26% $0.00 1.73M Jun 4, 2024 Common Stock 40K $4.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market in order to fund the exercise price and tax withholding of the exercise of the stock option.
F2 Derivative securities vested in three annual tranches beginning on January 2, 2019.